{"name":"NuCana plc","slug":"nucana-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQZThVWUZzV1hkNHZhZF9QRmNkQjFDVEJSQzkzZjNDVnhLMDgwVE5ZVlpfdVNRLXJ6UWxyS2lObUh0LUZWVndiUGdRaGZOU3p3T2JOdzdNeWtqUzlYSVVGa05tMWUtTE5MaUZTM21PNVJVX3VOTVQxXzBkQ3QtMkJSUTlScU0wSXdxS054RGJ1OVFXLUpzNlJCbmF5TlJROFFudjh3bWVyODlYS1Z6T0ZONTByZkNxeXgtV3VXRWJRdGhpQ1U4TWc?oc=5","date":"2026-03-13","type":"pipeline","source":"AD HOC NEWS","summary":"NuCana plc Stock Struggles as Biotech Volatility Persists Into March 2026 - AD HOC NEWS","headline":"NuCana plc Stock Struggles as Biotech Volatility Persists Into March 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPdXlNa2JpTFVJWWFGd3ZvVGZEZ0hUNE9fa0xoQmFFOUxyakM5Y0l6a0hWeVBuUGZCQnNMMDJEazRFczBtOHQ1Yl9ZYTZ0SWh5blVVamJzMjhJdGlhSFZUSnpKMjZ4R3hTdzFYN3dXOTZoZkpxbVlSMFhDX1I2ZEctSjRSeGNpalBaYVE?oc=5","date":"2025-08-01","type":"pipeline","source":"Stock Titan","summary":"NuCana Plans 1:200 Reverse Split: Strategic Move to Meet Nasdaq Requirements and Boost Stock Value - Stock Titan","headline":"NuCana Plans 1:200 Reverse Split: Strategic Move to Meet Nasdaq Requirements and Boost Stock Value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9OWjRBRWFKRXc4aWtrb3cwazhGb29XQXpITHM5bXBQWEplY0l3TE91SXJiTkUzNFhSZTJfYV8wRUdjc0gxOGs2R1pNUDlQdzNHZk1hWTA5Z0dackJZVm44czJVNmM2ZG56?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"NuCana (NCNA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"NuCana (NCNA) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPZG5KdFpHckRkM0JURGw2N0Rrd05kXzBtcEFPSzRFbklBLThKMzVsTUs4S0FLRFFadzEtc1ZqSl9NVkk1MXVvTzFzRUlzZENXZGhWMTRIT2lFd0ZVa1pUQmZzUkplOXlyQlFLS3N3dlVsb29sc1N4eVMtTmpRTHJVUDVEZ3pueTAyOXhvdUd0NFR1Z2o1Nmp1dEwxbU93d29PdDlWWkxrNkpKdk90V3h0VllyUTJXdTVmazcxdA?oc=5","date":"2025-06-02","type":"trial","source":"Stock Titan","summary":"NuCana's Melanoma Breakthrough: Key Drug Advances to Expansion Trial, Q1 Losses Drop 63% Year-over-Year - Stock Titan","headline":"NuCana's Melanoma Breakthrough: Key Drug Advances to Expansion Trial, Q1 Losses Drop 63% Year-over-Year","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOUGVSM3duNWdnWXliS2toUlc5dUYxRmdxQVFDd1pqR24tQVc4YTBILUI5ZW12RnU0cGJsQjdNS21Cd1VsYVB6aVc4azc1ck54aWJoQ3RrcEFCODhUQWJvdWdaR1dJXzl1UDZBU1hrbmhvWnRSRkI5dW02LUFOUFVsazM2WHpkQlFJTVozOHpsaVUtMFpLeEV2b0ppbnYxVFZNMzlkcGw5ZVF5YmtOWkRETmJsZllHLUxYQ0RDeg?oc=5","date":"2025-02-10","type":"pipeline","source":"Business Wire","summary":"Aurion Biotech Appoints Donald Munoz as Chief Financial Officer - Business Wire","headline":"Aurion Biotech Appoints Donald Munoz as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPcEM0OHQxLW9ZUk5kVi16bk1kQ3hzd0g4NTNaN3g1Z3VhWmhrWC0zTU9wdzBlNU0xRGptazVaMThjTW5lQUZyMzhRc0J2R09uT3N5LTlkd0ZPZkpmQ011QlgxX0xhSUpDdXZqZ3F3eXdoaWhHdkN3em9qMjdHTm5KR04za1hOQmhQaGg4ZWJGWQ?oc=5","date":"2024-01-03","type":"pipeline","source":"seekingalpha.com","summary":"NuCana Stock: Potential Turnaround In 2024 But Risky (NASDAQ:NCNA) - seekingalpha.com","headline":"NuCana Stock: Potential Turnaround In 2024 But Risky (NASDAQ:NCNA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE85Zzh2WlU0X3YycHZ3RmVMRGQ2WUtCSFE1ekZyd1F1RkhMQ1ZwUkxMNV83VGt1d1hMdFhzdkR5emJNNlV6amlPWkRjWVo3YVQ1ZHNSZnd1MTZxU3NtUVpybjVrUEdlbGdON1ZBdGxR?oc=5","date":"2020-08-14","type":"pipeline","source":"MarketBeat","summary":"NuCana (NCNA) Short Interest & Short Float | Updated Apr 2026 - MarketBeat","headline":"NuCana (NCNA) Short Interest & Short Float | Updated Apr 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNNWVuSnVBcjVXMTdxYW1vQ2dlQm4ydGVoVjU1QXVsLXptRDhpN0pYdHFDd2dKazI1OEx5SklZdjlEb3dkYzNJMnFZRXJfWHNWaklIQnVzRGdOYWRXZnpJVFl1LTZ5OE1LTFRTV19XUGFIcjdHZTI1Ym5rNHIwWnYwQ3FLdw?oc=5","date":"2017-12-18","type":"pipeline","source":"BioPharma Dive","summary":"Biotech IPOs show no signs of slowing down in 2018 - BioPharma Dive","headline":"Biotech IPOs show no signs of slowing down in 2018","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9IdHJxdDE4QVl5MGJqdVJoZXI2ajJLMVd4QVBweXRqWXI4RHJ6R01lVjhpdUNNVEhmUWlnMzUzMF9mNkxPbl94MmZNbWxtblFrTFE?oc=5","date":"2017-05-06","type":"pipeline","source":"Yahoo Finance UK","summary":"Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, quote and history - Yahoo Finance UK","headline":"Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}